In the modern era, patients undergoing percutaneous coronary interventions (PCI) often present increasingly challenging profiles due to both comorbidities and anatomical complexity. In this context, there is growing awareness that performing ultra-low-dose contrast PCI significantly enhances the safety and quality of these interventions.

Most cardiac patients fall into the high-risk category for acute kidney injury (AKI). Contrast-induced acute kidney injury (CI-AKI) is a serious complication following coronary angiography (CAG) and PCI, particularly in patients with chronic kidney disease (CKD). The development of CI-AKI prolongs hospitalization, increases financial burdens, and adversely impacts both short-term and long-term mortality rates, especially in those with advanced CKD.

Ultra-low-dose contrast percutaneous coronary intervention (PCI) is a valuable approach for selected complex, high-risk patients with renal failure. One of the primary objectives of ultra-low-contrast PCI is to reduce the risk of developing postprocedural contrast-induced nephropathy (CIN), which predominantly affects patients with baseline renal dysfunction. ULCPCI can be performed electively in cases of advanced chronic kidney disease. Minimizing contrast exposure and potentially using the least nephrotoxic contrast agents are critical considerations during angiography and PCI in patients with pre-existing CKD.

Yashoda Hospitals is a leading Center of Excellence for Heart Care in India, with over three decades of healthcare expertise. Our Heart Institute comprises renowned cardiac surgeons, cardiac anesthesiologists, cardiac radiologists, and interventional cardiologists who are extensively trained in advanced technologies and have vast experience in performing cutting-edge procedures. The institute features state-of-the-art facilities, including advanced Cath labs, ICUs, OCT, and ECMO, which complement the expertise of our cardiologists, enabling optimal patient care for advanced, complex surgeries and procedures.

As one of the largest quaternary care hospitals in the country, Yashoda Hospitals specializes in treating high volumes of cardiac patients, particularly through minimally invasive procedures, ensuring the best outcomes for our patients.